Ucb Biopharma Srl

This study looks at the long-term safety of a drug called rozanolixizumab in children aged 2 and older with generalized myasthenia gravis, a condition that causes muscle weakness. Participants will receive additional 6-week treatment cycles. The goal is to monitor serious side ef…

This study tests whether the drug brivaracetam can stop absence seizures in people aged 2 to 25 with childhood or juvenile absence epilepsy. Participants receive either the drug or a placebo, and their brain activity is monitored with an EEG to see if seizures disappear. The goal…

This early-stage study is testing the safety and tolerability of an experimental drug called UCB0022 in 32 healthy adults of Caucasian, Japanese, and Chinese backgrounds. Participants receive either the drug or a placebo, and researchers monitor for side effects and how the drug …